The Effects of Menopausal Status, Isoflavone Supplementation and Training on Cardiometabolic Function Women
In plain words A study of red Clover in female participants 45 to 61, run by University of Copenhagen. It plans to enroll about 60 people at 2 sites, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists female participants 45 to 61; healthy volunteers accepted. Conditions: Menopause; Exercise Adaptation; Mitochondrial Alteration; Vascular Function in Healthy Volunteers.
- Women aged ≥45 and <61 years.
- Either *
- *Regular menstrual cycles (premenopausal group), or
- *More than 5 years since the last menstrual period (postmenopausal groups).
2 more inclusion criteria and the exclusion criteria are on the listing.
What it tests, as registered
Red Clover Isoflavone Supplementation; Supervised exercise training; Placebo Supplementation
Registered summary
The goal of this clinical trial is to investigate the role of estrogen and isoflavone supplementation in exercise-induced cellular signaling and cardiometabolic adaptations in premenopausal and postmenopausal women. The study will evaluate vascular function, mitochondrial function, acute and long-term exercise responsiveness, and menopause-related outcomes. The full summary is on the listing.
Where, as registered
No US site; Denmark (2).